BIO-TECHNOLOGY LIMITED

Yes. In statutory due diligence and corporate verification, BIO-TECHNOLOGY LIMITED is authenticated as a lawful Private company limited by shares established on 1979-07-06 under the Companies Ordinance (Cap. 622) (duration: 47 years). Official registry indices confirm its current standing as [Live / In Operation] with active corporate capacity (Last verified: October 2026).

Official Hong Kong government registers assign two statutory identifiers to BIO-TECHNOLOGY LIMITED: 1. Business Registration Number (BRN / UBI): [06368537] (statutory identifier for tax and commercial registration under Cap. 310); 2. Company Registration Number (CRN): [0071125] (statutory filing number under Cap. 622). Commercial counterparties should verify both numbers on contracts and invoices.

In Hong Kong corporate compliance and banking KYC due diligence, verifying the decision-makers of BIO-TECHNOLOGY LIMITED requires cross-checking three statutory filings: 1. Latest Annual Return (Form NAR1) for issued share capital and shareholder equity percentages; 2. Form ND2A (Notice of Change of Company Secretary and Director) for interim board changes after the annual return date; and 3. Significant Controllers Register (SCR) penetration for natural persons or holding entities exercising ultimate control (UBO).

Yes. According to the official statutory records of the Hong Kong Companies Registry, BIO-TECHNOLOGY LIMITED has officially recorded 1 legal name change(s): [BIO-TECHNOLOGY LIMITED (effective 1979-07-06)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Pursuant to the Companies Ordinance (Cap. 622), statutory filings delivered by BIO-TECHNOLOGY LIMITED—such as Incorporation Forms (Form NNC1), Annual Returns (Form NAR1 under Section 662), and notices of director or registered office changes (Form ND2A / Form NR1)—are maintained by the Hong Kong Companies Registry. Where online electronic image indexing is pending synchronization or involves early historical microfiche archives, manual statutory retrieval from the Companies Registry can be commissioned through our compliance team.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Register Screening: Multi-agency verification across Hong Kong statutory regulators confirms BIO-TECHNOLOGY LIMITED does not hold special administrative or financial licences (such as SFC, HKMA, TCSP, or MSO), engaging in general commercial operations under the Companies Ordinance (Cap. 622); 2. Judicial Screening (Litigation & Winding-Up): judicial screening has identified compulsory winding-up petition records (High Court HCCW docket under Cap. 32) filed against the company, indicating critical corporate liquidation and insolvency risk. Immediate inspection of petition dockets and Official Receiver's Office (ORO) notices is recommended.

The statutory registered office of BIO-TECHNOLOGY LIMITED is registered at: [10/F, STELUX HOUSE, 698 PRANCE EDWARD ROAD EAST, SAN PO KONG, HONG KONG]. In accordance with Cap. 622 Section 658 and Cap. 622B Section 3, this Hong Kong address serves as the statutory venue for inspection of statutory registers, service of government and judicial process, and mandatory display of the corporation's full legal name.

Before entering into cross-border trade, credit settlement, or joint venture agreements with BIO-TECHNOLOGY LIMITED (CRN: 0071125 / 8-digit BRN: 06368537), standard institutional due diligence under Hong Kong law comprises four core verifications: 1. Standing & Identifier Match: Cross-checking active status under Cap. 622 and its 8-digit BRN under Cap. 310; 2. Equity & Signatory Penetration: Inspecting the latest Annual Return (Form NAR1) and Form ND2A to verify paid-up share capital, shareholders, and authorized signatory directors; 3. Register of Charges Screening: Checking Form NM1 filings under Part 8 (Section 334) of Cap. 622 for pledged corporate assets or bank floating charges; and 4. Judicial Screening: Verifying the absence of High Court winding-up petitions (HCCW) or civil litigation writs.